hotspot -WSS

hotspot

author：explore 2025-09-06 03:30:55 - browse：58

Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: The latest on Amylyx, Moderna, Novavax

explore

focus

hotspot

WSS

Adopting new red light myopia treatments may be short

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Elisabeth Bik tackles the widespread issue of research misconduct

Cholera vaccine supplies dangerously low, outbreaks surging

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Pfizer is about to make a big push in cancer. Will investors listen?

entertainment

hotspot

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Cano Health’s bankruptcy is a warning for Medicare Advantage

Virginia high school admissions case could be legal follow

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Malaria cases in Florida and Texas: Here’s what you need to know

Global cancer cases to surge 77% by 2050, WHO report says

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare Advantage isn’t working — for anyone

Bright Health sells Medicare Advantage business to Molina

AI gets buy

explore

Adopting new red light myopia treatments may be short

A single Democrat is willing to weaken Medicare negotiation power

The CDC's new social media misinformation war

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Medicare isn't yet testing food as medicine

explore

focus

hotspot

leisure time